Cullinan Therapeutics
(NASDAQ) CGEM
Cullinan Therapeutics Financials at a Glance
Market Cap
$873.39M
Revenue (TTM)
$0.00
Net Income (TTM)
$219.88M
EPS (TTM)
$-3.72
P/E Ratio
-3.88
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$14.44
Volume
1,149,608.267
Open
$13.51
Price
$14.44
Volume
1,149,608.267
Open
$13.51
Previous Close
$14.43
Daily Range
$13.51 - $14.62
52-Week Range
$5.68 - $16.74
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$14.44
Volume
1,149,608.267
Open
$13.51
Previous Close
$14.43
Daily Range
$13.51 - $14.62
52-Week Range
$5.68 - $16.74
CGEM News
CGEM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cullinan Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
109
CEO
Nadim Ahmed
Website
www.cullinantherapeutics.comHeadquarters
Cambridge, MA 02142, US
CGEM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-44%
Return on Capital
-59%
Return on Assets
-49%
Earnings Yield
-25.77%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$873.39M
Shares Outstanding
60.53M
Volume
1.15M
Short Interest
0.00%
Avg. Volume
796.91K
Financials (TTM)
Gross Profit
$311.00K
Operating Income
$241.65M
EBITDA
$241.65M
Operating Cash Flow
$175.75M
Capital Expenditure
$49.00K
Free Cash Flow
$175.80M
Cash & ST Invst.
$377.90M
Total Debt
$2.68M
Cullinan Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$79.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$873.39M
N/A
Market Cap/Employee
$7.87M
N/A
Employees
111
N/A
Net Income
$50.71M
-6.4%
EBITDA
$60.48M
-10.0%
Quarterly Fundamentals
Net Cash
$375.21M
-5.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$1.90M
+124.1%
Short Term Debt
$780.00K
-40.1%
Return on Assets
-49.04%
N/A
Return on Invested Capital
-58.85%
N/A
Free Cash Flow
$38.12M
-4.1%
Operating Cash Flow
$38.11M
-4.0%